Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02830334 · ClinicalTrials.gov registry record
Use of the Ask Suicide-Screening Questions (ASQ) in Pediatric Outpatient Settings
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Terminated
- Registry status
- 525
- Enrollment target
NCT02830334: Clinical Trial study, sponsored by National Institute of Mental Health (NIMH).
NCT02830334 is a clinical trial that was terminated before completion, run by National Institute of Mental Health (NIMH). The registered enrollment target is 525 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02830334 was terminated before completion, sponsored by National Institute of Mental Health (NIMH).
- TERMINATED
- Registry status
- 525 participants
- Enrollment target
Study Summary
Background: Doctors and nurses who work in non-mental health settings need ways to know when patients are at risk. Researchers created the Ask Suicide-Screening Questions (ASQ) to be used in an emergency department for children. This is a 4-item suicide risk screening tool. We wanted to see if this is also a good tool to use in the outpatient setting. Two studies are being done to test it at hospitals. This study is for researchers to analyze the data from those two studies. Objectives: To combine and analyze data from two studies to see how well the ASQ can detect suicide risk in pediatric outpatient clinics. Eligibility: No people are enrolled in this study. Design: Participants in the two non-NIH studies will give consent for their data to be shared. The data will be confidential and secure. They will have no personal information attached to them. Researchers will get the data and analyze them.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 525 participants |
| Start Date | 2016-07-09 |
| Est. Completion | 2020-04-22 |
Why NCT02830334 stopped before completion
NCT02830334 is an observational study that tracks outcomes without assigning an intervention. The registered 525 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02830334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02830334 about?
NCT02830334 is a clinical study titled "Use of the Ask Suicide-Screening Questions (ASQ) in Pediatric Outpatient Settings". Background: Doctors and nurses who work in non-mental health settings need ways to know when patients are at risk. Researchers created the Ask Suicide-Screening Questions (ASQ) to be used in an emergency department for children. This is a 4-item suicide risk screening tool. We wanted to see if this...
What is the current status of trial NCT02830334?
This trial is currently terminated. The enrollment target is 525 participants. The study started on 2016-07-09. Estimated completion is 2020-04-22.
Who is sponsoring clinical trial NCT02830334?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04769492 · 525 participants · NA
#ChopViolence/#ChopHIV
- NCT05260047 · 525 participants · NA
Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
- NCT05620719 · 525 participants · NA
Multisite Advancement of Research on Chronic Posttraumatic Headache
- NCT06496646 · 525 participants · NA
Antidepressant Adherence for Depressed Adults in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI